Blood Banking (Diagnostics)

Company Reports on HIV-1 p24 Antigen Assay

Published in AIDS Weekly, February 26th, 1996

The Coulter Corporation, Miami, Florida, announces that they have received an "approvable letter" from the U.S. Food and Drug Administration (FDA) for a new blood screening product, the Coulter HIV-1 p24 Antigen Assay, which is intended to detect the presence of the HIV-1 p24 antigen.

The product, developed and produced by the Coulter Corporation, is intended for use by blood and plasma collection centers nationwide to screen blood samples for the presence of HIV-1. Ortho Diagnostic Systems Inc., will market the product on an exclusive basis after FDA approval.

Studies show that there is a window period of about 25 days between the time a person...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1996-02-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry